Ling Ding is a postdoctoral research associate in the Department of Pharmacy Practice and Science at the University of Nebraska Medical Center. Ding is a pharmaceutical scientist with over 7 years of experience in drug/gene delivery, formulation, and characterization of nanomaterials, 1-year experience in clinical pharmacology study, and LC-MS/MS training. Ding has expertise in various polymer-based drug/gene delivery systems, pharmacokinetic evaluation, in vitro/vivo toxicity, and therapeutic efficacy. Ding has extensive experience working with a range of animal models, including inflammation/fibrosis animal models (IPF, AKI, ALI, AALD, liver/kidney fibrosis) and various orthopedic tumor models (PDAC, liver/lung metastasis, breast cancer, NSCLC). Ding is proficient in designing and performing experiments with data collection, validation, and interpretation. Persistent and effective, adaptive and quick learning with high strong collaborative attitude.